• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Life Sciences | News, Analysis, Insights - HIT Consultant

Benchling Launches New Products for Research & Biotech Startups to Accelerate Life Sciences Innovation

by Jasmine Pennic 09/19/2019 Leave a Comment

Benchling Launches New Products for Research & Biotech Startups to Accelerate Life Sciences Innovation

- Benchling launches two new products that will democratize access to industry-leading data management and collaboration software to the places they happen most: institutions and startup.- With Benchling, organizations from academic institutions, to startups, to major enterprises, can accelerate the pace at which they develop scientific breakthroughs, while minimizing time-consuming, antiquated processes. - The Benchling platform enables scientists to manage the complexity of biology research
Read More

AI-Driven Drug Discovery Startup Unnatural Products Nabs $6M

by Jasmine Pennic 09/17/2019 Leave a Comment

ARTIS Ventures Backs AI-Driven Drug Discovery Startup Unnatural Products

- Drug discovery startup Unnatural Products, Inc. pairing AI with chemistry to create treatments for drug targets raise $6M in funding led by ARTIS Ventures. - Unnatural Products uses a combination of machine learning and parallel chemistry to change the way we think about treating disease Today ARTIS Ventures has led a $6 million seed round for Unnatural Products, Inc., a Santa Cruz, CA-based drug discovery startup pairing AI with chemistry to create treatments for drug targets that aren’t
Read More

Ensuring A Healthy Approach to Big Data In The Life Sciences Industry

by Ferdi Steinmann, Industry Strategist for Life Sciences, OpenText 09/17/2019 Leave a Comment

Ensuring a Healthy Approach to Big Data in the Life Sciences Industry

The old adage “knowledge is power” may seem cliched, but it definitely still rings true in the life sciences industry. In fact, maybe more so than in any other industry, healthcare insights are being driven by a vast array of critically important data from scientific research, clinical trials, and patient profiling. Teams are continually asked to identify, prioritize and develop promising therapies which are not only safe but innovative, effective and based on the latest research. To achieve
Read More

BrightInsight Nabs $25M for Regulated IoT Platform for Biopharma and Medtech

by Fred Pennic 09/05/2019 Leave a Comment

BrightInsight Nabs $25M for Regulated IoT Platform for Biopharma and Medtech

- BrightInsight raises $25M in Series A funding co-led by New Leaf Venture Partners and Eclipse Ventures to further enhance the functionality of its BrightInsight Platform and accelerate global commercialization efforts. - BrightInsight platform enables regulated drugs, devices and SaMDs to ingest and analyze data and deploy regulated recommendations and insights back to patients and providers BrightInsight, San Jose, CA-based global regulated digital health platform for biopharma and
Read More

Life Image Launches Real World Imaging for RWE Programs

by Jasmine Pennic 09/05/2019 Leave a Comment

Life Image Launches Real World Imaging for RWE Programs

- Life Image launches Real World Imaging (RWI) offering to respond to researcher needs for maturing insights and accelerating drug development decisions.  - Imaging data, especially for Real World Evidence (RWE), has historically been difficult, if not impossible, to access, retrieve, view, de-identify and normalize at-scale, even though it provides clinically material insights for a growing number of therapies. - Life Image represents the only company providing large, heterogeneous,
Read More

Tufs Study: Cancer Drugs Now Account for 27% of all New Drug Approvals

by Jasmine Pennic 09/03/2019 Leave a Comment

Cancer drugs currently account for 27% of all new drug approvals in the United States since 2010, a dramatic increase from the 4% share of the 1980s,

Quick Glance- Cancer drugs currently account for 27% of all new drug approvals in the United States since 2010- From 1980 through 2018, the Food and Drug Administration (FDA) approved a total of 126 cancer drugs to treat solid and hematologic tumors- New approaches to development helped to drive the surge in new oncology products, including improvements in clinical trial design, novel drug formats, and a focus on new and validated targetsCancer drugs currently account for 27% of all new drug
Read More

KPMG, Coriell Life Sciences Collaborate on Pharmacogenomics Testing

by Jasmine Pennic 08/28/2019 Leave a Comment

KPMG, Thermo Fisher, Coriell Life Sciences Collaborate to Offer Pharmacogenomics Testing

Coriell Life Sciences will provide pharmacogenomic tests for clients of KPMG’s Care Continuum Optimization, a cloud-based data platform aimed at improving healthcare outcomes and guiding clinicians through transitions in care.  Coriell will be running the tests on Thermo Fisher Scientific technology to provide alerts to prescribers when there is the potential for an adverse drug event tied to a patient’s genetics and recommend safer treatment options.KPMG’s Care Continuum Optimization
Read More

Quest Diagnostics to Contribute Biomarker Datasets to Support One Brave Idea Initiative

by Fred Pennic 08/07/2019 Leave a Comment

Quest Diagnostics to Contribute Biomarker Datasets to Support One Brave Idea Initiative

In a move to advance the ground-breaking work to identify coronary heart disease at the earliest transition from wellness to disease, Quest Diagnostics announced it will contribute biomarker implementation, population health analytics and a national lab platform as a pillar supporter of One Brave Idea, the research initiative co-founded by the American Heart Association (AHA) and Verily Life Sciences with significant support from AstraZeneca.The Burden of Cardiovascular DiseaseHeart disease is
Read More

Litmus Health Launches Next-Generation Data Science Platform for Clinical Research

by Fred Pennic 08/07/2019 Leave a Comment

Litmus Health Launches Next-Generation Data Science Platform for Clinical Research

 Litmus Health, the research-ready infrastructure platform for real-world data has announced the release of the next generation of their platform focused on reliable data engineering, data quality, and flexible deployment. The end-to-end platform supports the entire trial process: from data collection at the point of experience to laboratory analytics that can inform decision making.Pharma Industry Increasingly Turning to Real-World DataThe pharmaceutical industry has been increasingly looking
Read More

Benchling Nabs $34.5M to Power Life Sciences R&D Cloud Platform

by Jasmine Pennic 07/25/2019 Leave a Comment

Benchling Nabs $34.5M to Power Life Sciences R&D Cloud Platform

Benchling, a San Francisco, CA-based life sciences R&D cloud platform announced it has raised $34.5 million in Series C funding led by Menlo Ventures with new investors Lead Edge Capital and Y Combinator Continuity as well as returning investors Benchmark and Thrive Capital.  Replacing Outdated Pen and Paper Processes Life science R&D has become incredibly complex -- from the molecules to the processes to the multi-dimensional data. Until Benchling, there had been
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 88
  • Go to page 89
  • Go to page 90
  • Go to page 91
  • Go to page 92
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Digital Health Funding Q3 2025: Choppy Undercurrents Beneath a Steady Surface

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Oracle Confirms Layoffs in Kansas City

Oracle Confirms Layoffs in Kansas City

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Optain Health Secures $26M to Advance AI-Powered Retinal Screening

Optain Health Secures $26M for AI-Powered Retinal Screening

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |